Clinical Trial Update: Comparative, Multicenter Study in Subjects with Rheumatoid Arthritis, ALVOFLEX [Phase 3]

View source ↗

Summary

A Phase 3, multicenter comparative trial evaluating ALVOFLEX for rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ALVOFLEX (adalimumab)

Snippet

Sponsor: Alvotech Swiss AG | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED